What is Accelerator?
Accelerator Life Science Partners is dedicated to catalyzing the development and commercialization of breakthrough biotechnology innovations. The company provides a comprehensive business, scientific, and financial toolkit essential for establishing and operating early-stage biotechnology ventures. By nurturing companies through all stages of development, Accelerator aims to maximize their chances of long-term success. Key resources include committed investment capital, experienced start-up management, world-class scientific expertise, and state-of-the-art laboratory facilities. This unique collection of capabilities is facilitated through partnerships with top-tier investors, seasoned executive managers, and numerous world-class research institutions. The company's partners possess extensive experience in transforming novel ideas into viable commercial products, offering critical knowledge to streamline the development and commercialization of new technologies. The value of these collective resources has been demonstrated over more than a decade of successful investment in life science companies shaping the future of medicine and healthcare.
How much funding has Accelerator raised?
Accelerator has raised a total of $49.3M across 3 funding rounds:
Other Financing Round
$15M
Other Financing Round
$11.8M
Series C
$22.5M
Other Financing Round (2003): $15M with participation from ARCH Ventures
Other Financing Round (2004): $11.8M led by ARCH Ventures
Series C (2007): $22.5M supported by ARCH Ventures
Key Investors in Accelerator
ARCH Ventures
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
ARCH Ventures
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
ARCH Ventures
ARCH Venture Partners is a leading early-stage venture capital firm that creates and invests in life sciences and advanced technology companies, often cofounding startups with scientists and entrepreneurs to commercialize innovations from universities, corporate R&D groups, and national laboratories.
What's next for Accelerator?
The recent major strategic investment signals a new phase of accelerated growth and development for Accelerator. This capital infusion is expected to bolster the company's capacity to nurture its portfolio companies, enhance its scientific and business support infrastructure, and potentially expand its network of research and investment partners. The company's focus on early-stage biotechnology suggests that this funding will be instrumental in bringing novel therapies and healthcare solutions to market, reinforcing its position as a key player in the life sciences ecosystem.
See full Accelerator company page
